BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31858232)

  • 1. Invariant natural killer T cells are reduced in peripheral blood of bullous pemphigoid patients and accumulate in lesional skin.
    Mathias LM; Harff M; Orth V; Hofmann SC
    Arch Dermatol Res; 2020 Dec; 312(10):747-751. PubMed ID: 31858232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invariant natural killer T cells are enriched at the site of cutaneous inflammation in lupus erythematosus.
    Hofmann SC; Bosma A; Bruckner-Tuderman L; Vukmanovic-Stejic M; Jury EC; Isenberg DA; Mauri C
    J Dermatol Sci; 2013 Jul; 71(1):22-8. PubMed ID: 23664188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue Factor in Dermatitis Herpetiformis and Bullous Pemphigoid: Link between Immune and Coagulation System in Subepidermal Autoimmune Bullous Diseases.
    Zebrowska A; Wagrowska-Danilewicz M; Danilewicz M; Wieczfinska J; Pniewska E; Zebrowski M; Waszczykowska E; Wozniacka A; Eusebio M; Pietruczuk M; Pawliczak R
    Mediators Inflamm; 2015; 2015():870428. PubMed ID: 27057091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two flow cytometric methods for detection of human invariant natural killer T cells (iNKT).
    Fereidouni M; Jabbari Azad F; Mahmoudi M; Varasteh A; Farid Hosseini R
    Iran J Immunol; 2010 Mar; 7(1):1-7. PubMed ID: 20371914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometry analysis of peripheral blood lymphocytes from patients with bullous pemphigoid.
    Jouen-Beades F; Joly P; Héron F; Paris E; Lauret P; Tron F
    Dermatology; 1998; 197(2):137-40. PubMed ID: 9732162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced numbers of circulating gammadelta T cells in patients with bullous pemphigoid.
    Oswald E; Fisch P; Jakob T; Bruckner-Tuderman L; Martin SF; Rensing-Ehl A
    Exp Dermatol; 2009 Nov; 18(11):991-3. PubMed ID: 19469889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo analysis of IgE autoantibodies in bullous pemphigoid: a study of 100 cases.
    Moriuchi R; Nishie W; Ujiie H; Natsuga K; Shimizu H
    J Dermatol Sci; 2015 Apr; 78(1):21-5. PubMed ID: 25724363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invariant NKT cells are expanded in peripheral blood but are undetectable in salivary glands of patients with primary Sjögren's syndrome.
    Guggino G; Ciccia F; Raimondo S; Giardina G; Alessandro R; Dieli F; Sireci G; Triolo G
    Clin Exp Rheumatol; 2016; 34(1):25-31. PubMed ID: 26633038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invariant natural killer T cells in chronic obstructive pulmonary disease.
    Chi SY; Ban HJ; Kwon YS; Oh IJ; Kim KS; Kim YI; Kim YC; Lim SC
    Respirology; 2012 Apr; 17(3):486-92. PubMed ID: 22098381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T cells in skin lesions and blood of patients with bullous pemphigoid.
    Antiga E; Quaglino P; Volpi W; Pierini I; Del Bianco E; Bianchi B; Novelli M; Savoia P; Bernengo MG; Fabbri P; Caproni M
    J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):222-30. PubMed ID: 23331964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invariant Natural Killer T Cell Deficiency and Functional Impairment in Sleep Apnea: Links to Cancer Comorbidity.
    Gaoatswe G; Kent BD; Corrigan MA; Nolan G; Hogan AE; McNicholas WT; O'Shea D
    Sleep; 2015 Oct; 38(10):1629-34. PubMed ID: 26414901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased frequency and proliferative response of invariant Valpha24Vbeta11 natural killer T (iNKT) cells in healthy elderly.
    Peralbo E; DelaRosa O; Gayoso I; Pita ML; Tarazona R; Solana R
    Biogerontology; 2006; 7(5-6):483-92. PubMed ID: 16953330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Activation of Unconventional T Cells, Including iNKT Cells, in Alcohol-Related Liver Disease.
    Marrero I; Maricic I; Morgan TR; Stolz AA; Schnabl B; Liu ZX; Tsukamoto H; Kumar V
    Alcohol Clin Exp Res; 2020 May; 44(5):1061-1074. PubMed ID: 32154597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lesional Th17 cells and regulatory T cells in bullous pemphigoid.
    Arakawa M; Dainichi T; Ishii N; Hamada T; Karashima T; Nakama T; Yasumoto S; Tsuruta D; Hashimoto T
    Exp Dermatol; 2011 Dec; 20(12):1022-4. PubMed ID: 22017210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mediators of mast cells in bullous pemphigoid and dermatitis herpetiformis.
    Zebrowska A; Wagrowska-Danilewicz M; Danilewicz M; Stasikowska-Kanicka O; Kulczycka-Siennicka L; Wozniacka A; Waszczykowska E
    Mediators Inflamm; 2014; 2014():936545. PubMed ID: 25400334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease in eosinophils infiltrating into the skin of patients with dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid.
    Chijiwa C; Takeoka S; Kamata M; Tateishi M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Watanabe S; Tada Y
    J Dermatol; 2018 May; 45(5):596-599. PubMed ID: 29411416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Activity and Apoptosis of Eosinophils in Blister Fluids, Skin and Peripheral Blood of Patients with Bullous Pemphigoid.
    Engmann J; Rüdrich U; Behrens G; Papakonstantinou E; Gehring M; Kapp A; Raap U
    Acta Derm Venereol; 2017 Apr; 97(4):464-471. PubMed ID: 27868136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invariant Natural Killer T Cells are Reduced in Hereditary Hemochromatosis Patients.
    Maia ML; Pereira CS; Melo G; Pinheiro I; Exley MA; Porto G; Macedo MF
    J Clin Immunol; 2015 Jan; 35(1):68-74. PubMed ID: 25479931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse association of peripheral blood CD4(+) invariant natural killer T cells with atopy in human asthma.
    Koh YI; Shim JU; Wi JO; Han ER; Jin NC; Oh SH; Park CK; Park DJ
    Hum Immunol; 2010 Feb; 71(2):186-91. PubMed ID: 19879910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
    Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
    J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.